Amicus Therapeutics (FOLD)

• Market cap: $2.73B
• 1 day: -0.23%
• 5 days: 4.48%
• 1 month: 11.59%
• 3 months: 44.77%
• 6 months: 19.89%
• Year to date: -4.83%
• 1 year: -23.09%
• 5 years: -51.48%
• 10 years: 20.54%
• Sector: Healthcare
• Industry: Biotechnology

About: Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Employees: 499